Format

Send to

Choose Destination
Cornea. 2008 Jan;27(1):1-16. doi: 10.1097/ICO.0b013e31815892da.

Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions.

Author information

1
Department of Ophthalmology, Emory University, Atlanta, GA, USA. ophtbmc@emory.edu

Abstract

Specular microscopy can provide a noninvasive morphologic analysis of the corneal endothelial cell layer from subjects enrolled in clinical trials. The analysis provides a measure of the endothelial cell physiologic reserve from aging, ocular surgical procedures, pharmaceutical exposure, and general health of the corneal endothelium. The purpose of this review is to discuss normal and stressed endothelial cell morphology, the techniques for determining the morphology parameters, and clinical trial applications.

PMID:
18245960
PMCID:
PMC3062434
DOI:
10.1097/ICO.0b013e31815892da
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center